Page last updated: 2024-08-18

acrolein and Cardiomegaly

acrolein has been researched along with Cardiomegaly in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, H; Guo, W; Lu, R; Qian, D; Shan, X; Tian, J; Wang, S; Xu, M; Zhang, C; Zhao, P	1

Other Studies

1 other study(ies) available for acrolein and Cardiomegaly

Article	Year
Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway. BMC complementary medicine and therapies, 2022, Apr-25, Volume: 22, Issue:1 Topics: Acrolein; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; MAP Kinase Signaling System; Mice; Myocytes, Cardiac; Phenylephrine; Rats; Ryanodine Receptor Calcium Release Channel	2022

Article

Year

Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway.

BMC complementary medicine and therapies, 2022, Apr-25, Volume: 22, Issue:1

Topics: Acrolein; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; MAP Kinase Signaling System; Mice; Myocytes, Cardiac; Phenylephrine; Rats; Ryanodine Receptor Calcium Release Channel

2022